Altered p53 and Bcl-2 expression in keratinocytes of vulvar lichen sclerosus during pimecrolimus treatment

British Journal of Dermatology

Volumn 161, Issue 4, 2009, Pages 958-960

  Nissi, R ^a   Kotila, V ^b   Knuuti, E ^a   Vare P O ^a   Kauppila, S ^c  

^a Lansi Pohja Central Hospital   (Finland)

^b UNIVERSITY OF OULU   (Finland)

^c OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Bcl 2; Lichen sclerosis; P53; Pimecrolimus

Indexed keywords

KI 67 ANTIGEN; PIMECROLIMUS; PROTEIN BCL 2; PROTEIN P53;

DRUG EFFECT; HUMAN; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; LETTER; LICHEN SCLEROSUS ET ATROPHICUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REMISSION; SCORING SYSTEM; SKIN BIOPSY;

FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KERATINOCYTES; PRECANCEROUS CONDITIONS; PROTO-ONCOGENE PROTEINS C-BCL-2; TACROLIMUS; TUMOR SUPPRESSOR PROTEIN P53; VULVAR LICHEN SCLEROSUS;

EID: 70349345900     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2009.09388.x     Document Type: Letter

References (10)

1. Carlson JA, Ambros R, Malfetano J et al. Vulvar lichen sclerosus and squamous cell carcinoma: a cohort, case control, and investigational study with historical perspective; implications for chronic inflammation and sclerosis in the development of neoplasia. Hum Pathol 1998 29 : 932 948.
2. Preti M, Rouzier R, Mariani L et al. Superficially invasive carcinoma of the vulva: diagnosis and treatment. Clin Obstet Gynecol 2005 48 : 862 868.
3. Hengge UR, Krause W, Hofmann H et al. Multicentre, phase II trial on the safety and efficacy of topical tacrolimus ointment for the treatment of lichen sclerosus. Br J Dermatol 2006 155 : 1021 1028.
4. Nissi R, Eriksen H, Risteli J et al. Pimecrolimus cream 1% in the treatment of lichen sclerosus. Gynecol Obstet Invest 2007 63 : 151 154.
5. Soini Y, Pääkkö P, Vähäkangas K et al. Expression of p53 and proliferating cell nuclear antigen in lichen sclerosus et atrophicus with different histological features. Int J Gynecol Pathol 1994 3 : 199 204.
6. Soufir N, Queille S, Liboutet M et al. Inactivation of the CDKN2A and the p53 tumour suppressor genes in external genital carcinomas and their precursors. Br J Dermatol 2007 156 : 448 453.
7. Rolfe KJ, Eva LJ, Maclean AB et al. Cell cycle proteins as molecular markers of malignant change in vulvar lichen sclerosus. Int J Gynecol Cancer 2001 11 : 113 118.
8. Raspollini MR, Asirelli G, Moncini D et al. A comparative analysis of lichen sclerosus of the vulva and lichen sclerosus that evolves to vulvar squamous cell carcinoma. Am J Obstet Gynecol 2007 197 : 592 597.
9. Bosari S, Roncalli M, Viale G et al. p53 immunoreactivity in inflammatory and neoplastic diseases of the uterine cervix. J Pathol 1993 169 : 425 430.
10. Feng W, Xiao J, Zhang Z et al. Senescence and apoptosis in carcinogenesis of cervical squamous carcinoma. Mod Pathol 2007 20 : 961 966.